Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | S8 |
| Molecular Weight | 256.52 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
S1SSSSSSS1
InChI
InChIKey=JLQNHALFVCURHW-UHFFFAOYSA-N
InChI=1S/S8/c1-2-4-6-8-7-5-3-1
| Molecular Formula | S8 |
| Molecular Weight | 256.52 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Mercury(I) iodide is a chemical compound that has been used as a drug in the 19th century, sometimes under the contemporary name of 'protiodide of mercury'. Mercury(I) iodide was used to treat a wide range of conditions; everything from acne to kidney disease and in particular was the treatment of choice for syphilis. It was available over the counter at any drugstore in the world, the most common form being a concoction of protiodide, licorice, glycerin, and marshmallow. Taken orally, and in low doses, protiodide causes excessive salivation, fetid breath, spongy and bleeding gums, and sore teeth. Excessive use or an overdose causes physical weakness, loss of teeth, hemolysing (destruction of the red blood cells) of the blood and necrosis of the bones and tissues of the body. Early signs of an overdose or excessive use are muscular tremors, chorea, and locomotor ataxia. Violent bloody vomiting and voiding also occur.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type. | 2014-08-22 |
|
| H2S inhibition of chemical hypoxia-induced proliferation of HPASMCs is mediated by the upregulation of COX-2/PGI2. | 2014-02 |
|
| Dexamethasone ameliorates H₂S-induced acute lung injury by alleviating matrix metalloproteinase-2 and -9 expression. | 2014 |
|
| Sulfide induces apoptosis and Rho kinase-dependent cell blebbing in Jurkat cells. | 2013-07 |
|
| A novel mechanism of formaldehyde neurotoxicity: inhibition of hydrogen sulfide generation by promoting overproduction of nitric oxide. | 2013 |
|
| Indoor air pollutants and health in the United Arab Emirates. | 2012-05 |
|
| Detoxification of methylmercury by hydrogen sulfide-producing enzyme in Mammalian cells. | 2011-10-17 |
|
| S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism. | 2011-06 |
|
| Time-series analysis of mortality effects of fine particulate matter components in Detroit and Seattle. | 2011-04 |
|
| HIF-1 and SKN-1 coordinate the transcriptional response to hydrogen sulfide in Caenorhabditis elegans. | 2011 |
|
| Disulfides as cyanide antidotes: evidence for a new in vivo oxidative pathway for cyanide detoxification. | 2009-12 |
|
| Multiple protective activities of neuroglobin in cultured neuronal cells exposed to hypoxia re-oxygenation injury. | 2009-03 |
|
| Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. | 2008-02 |
|
| Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. | 2008-02 |
|
| Emergency room visits for respiratory conditions in children increased after Guagua Pichincha volcanic eruptions in April 2000 in Quito, Ecuador observational study: time series analysis. | 2007-07-24 |
|
| The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. | 2005-09 |
|
| Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera. | 2005-08 |
|
| Induction of phase I, II and III drug metabolism/transport by xenobiotics. | 2005-03 |
|
| Major and trace elements in whole blood of phlebotomized patients with porphyria cutanea tarda. | 2005 |
|
| Production of the neuromodulator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine. | 2004-12-10 |
|
| A salivary incubation test for evaluation of oral malodor: a pilot study. | 2003-07 |
|
| Novel neural modulators. | 2003 |
|
| Fatal and nonfatal poisoning by hydrogen sulfide at an industrial waste site. | 2002-05 |
|
| Liquid chromatography/tandem mass spectrometric bioanalysis using normal-phase columns with aqueous/organic mobile phases - a novel approach of eliminating evaporation and reconstitution steps in 96-well SPE. | 2002 |
|
| HG/LT-GC/ICP-MS coupling for identification of metal(loid) species in human urine after fish consumption. | 2001-11 |
|
| Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis. | 2001-08 |
|
| Gas production by feces of infants. | 2001-05 |
|
| A fatal case of hydrogen sulfide poisoning in a geothermal power plant. | 1998-07 |
|
| The usefulness of thiosulfate as an indicator of hydrogen sulfide poisoning: three cases. | 1997 |
|
| Chemosensory event-related potentials in the investigation of interactions between the olfactory and the somatosensory (trigeminal) systems. | 1992-09 |
|
| Lung dysfunction in animal confinement workers--chairman's report to the Scientific Committee of the Third International Symposium: issues in health, safety and agriculture, held in Saskatoon, Saskatchewan, Canada, May 10-15, 1992. | 1992 |
|
| Activity of polymorphonuclear leukocytes in the presence of sulfide. | 1989-09 |
|
| Widespread occurrence of bacterial thiol methyltransferases and the biogenic emission of methylated sulfur gases. | 1987-07 |
|
| Clinical comparison of two radiocolloids for internal mammary lymphoscintigraphy. | 1985-12 |
|
| Convulsions following application of gamma benzene hexachloride. | 1981-07 |
|
| Investigations into black extrinsic tooth stain. | 1977-08 |
|
| NEPHROTIC SYNDROME CAUSED BY PROTIODIDE OF MERCURY. | 1965-03 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:15:03 GMT 2025
by
admin
on
Mon Mar 31 18:15:03 GMT 2025
|
| Record UNII |
70FD1KFU70
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QD10AB02
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
CFR |
21 CFR 310.531
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
CFR |
21 CFR 333.320
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
LOINC |
87449-5
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
CFR |
21 CFR 358.710
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
EPA PESTICIDE CODE |
77501
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
LOINC |
87450-3
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
WHO-ATC |
D10AB02
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
DSLD |
1352 (Number of products:160)
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
CFR |
21 CFR 333.310
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
||
|
CFR |
21 CFR 358.720
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
70FD1KFU70
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
231-722-6
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
SUB124719
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
ALTERNATIVE | |||
|
DTXSID80872924
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
7704-34-9
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
ALTERNATIVE | |||
|
66348
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
100000090444
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
C68289
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
403664
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
sulfur
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
m10377
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
7704-34-9
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
Sulfur (pharmacy)
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
70FD1KFU70
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
17909
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
221083
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
ALTERNATIVE | |||
|
26833
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
SULFUR
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
DTXSID9034941
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
4260
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
SUB15433MIG
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
7704-34-9
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
10223
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
m10369
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL2105487
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
D013455
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
Sulfur
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
10544-50-0
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY | |||
|
603623
Created by
admin on Mon Mar 31 18:15:03 GMT 2025 , Edited by admin on Mon Mar 31 18:15:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|